Capitol Health Limited (ASX: CAJ)

Market Cap	399.78M
Revenue (ttm)	234.82M
Net Income (ttm)	-14.85M
Shares Out	1.07B
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	28.78
Dividend	0.01 (2.07%)
Ex-Dividend Date	Sep 20, 2024

Volume	884,374
Open	0.370
Previous Close	0.375
Day's Range	0.360 - 0.375
52-Week Range	0.205 - 0.390
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 29, 2024

About Capitol Health

Capitol Health Limited provides diagnostic imaging modalities and related services to the healthcare market in Australia. It offers a range of diagnostic imaging services, including general x-ray, magnetic resonance imaging, ultrasound, mammography, Doppler, orthopantomogram, echocardiography, computed tomography, CT angiography, cone beam CT, nuclear medicine, bone densitometry, and fluoroscopy. It operates various clinics in Victoria, Tasmania, Western Australia, and South Australia under the Capital Radiology brand, as well as under the Imag...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2005
• Employees: 1,000
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CAJ

Financial Performance

In 2024, Capitol Health's revenue was 234.82 million, an increase of 12.03% compared to the previous year's 209.59 million. Losses were -14.85 million, 26.8% more than in 2023.